FDA Approved: DARIFENACIN — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved Cipla USA Inc.'s supplemental application for darifenacin hydrobromide (DARIFENACIN). This action expands regulatory clearance for this generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Darifenacin (darifenacin)

Snippet

SUPPL AP for DARIFENACIN (DARIFENACIN HYDROBROMIDE)